Sui‐Yuan Chang
About
Sui‐Yuan Chang is a scholar working on Infectious Diseases, Epidemiology and Virology.
According to data from OpenAlex, Sui‐Yuan Chang has authored 247 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Infectious Diseases, 74 papers in Epidemiology and 45 papers in Virology. Recurrent topics in Sui‐Yuan Chang's work include HIV/AIDS drug development and treatment (51 papers), SARS-CoV-2 and COVID-19 Research (46 papers) and HIV Research and Treatment (42 papers). Sui‐Yuan Chang is often cited by papers focused on HIV/AIDS drug development and treatment (51 papers), SARS-CoV-2 and COVID-19 Research (46 papers) and HIV Research and Treatment (42 papers). Sui‐Yuan Chang collaborates with scholars based in Taiwan, United States and China. Sui‐Yuan Chang's co-authors include Chien‐Ching Hung, S Chang, Hsin‐Yun Sun, Shan‐Chwen Chang, Chuan‐Liang Kao, Wen‐Chun Liu, Eric C. McGary, Chun‐Nan Lee, Hing C. Wong and K B Myambo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.
In The Last Decade
Sui‐Yuan Chang
238 papers receiving 5.5k citations
Peers
Sui‐Yuan Chang
Hong Zhang China
Miguel Ángel Martı́nez Spain
Andrea Carfı́ United States
Hans Wilhelm Doerr Germany
D. Lorne Tyrrell Canada
Christopher D. Richardson Canada
Andreas Meyerhans Germany
Jie Zhou China
Lu Lu China
Zhenghong Yuan China
Citations per year, relative to Sui‐Yuan Chang Sui‐Yuan Chang (= 1×)
peers
Hong Zhang
Countries citing papers authored by Sui‐Yuan Chang
Since
Specialization
Citations
This map shows the geographic impact of Sui‐Yuan Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sui‐Yuan Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sui‐Yuan Chang more than expected).
Fields of papers citing papers by Sui‐Yuan Chang
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Sui‐Yuan Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sui‐Yuan Chang. The network helps show where Sui‐Yuan Chang may publish in the future.
Co-authorship network of co-authors of Sui‐Yuan Chang
This figure shows the co-authorship network connecting the top 25 collaborators of Sui‐Yuan Chang. A scholar is included among the top collaborators of Sui‐Yuan Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sui‐Yuan Chang. Sui‐Yuan Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Tsai, Chin-Shiang, Hsin‐Yun Sun, Wen-Chi Huang, et al.. (2025). Chlamydia trachomatis infection among at-risk populations in Taiwan: Emergence of genovariant L2b and treatment response to antimicrobials. Journal of Microbiology Immunology and Infection. 58(3). 356–362.
2.
Huang, Yu‐Shan, Szu‐Min Hsieh, Feng‐Chiao Tsai, et al.. (2024). Serological responses to COVID-19 vaccination in patients with chronic liver diseases. Journal of the Formosan Medical Association.
3.
Chen, Chih‐Ping, Fang-Tzu Wu, Sui‐Yuan Chang, et al.. (2024). Low-level mosaic trisomy 14 at amniocentesis in a pregnancy associated with cytogenetic discrepancy between cultured amniocytes and uncultured amniocytes, positive non-invasive prenatal testing for trisomy 14, perinatal progressive decrease of the trisomy 14 cell line and a favorable fetal outcome. Taiwanese Journal of Obstetrics and Gynecology. 63(5). 755–758.
4.
Wang, Wei‐Jan, Wan‐Jou Shen, Chung‐Yu Chen, et al.. (2024). Novel SARS-CoV-2 inhibition properties of the anti-cancer Kang Guan Recipe herbal formula. Cancer Letters. 604. 217198–217198.
5.
Chen, Chih‐Ping, Fang-Tzu Wu, Sui‐Yuan Chang, et al.. (2024). Mosaic distal 13q duplication due to mosaic unbalanced translocation of 46,XY,der(14)t(13;14)(q32.2;p13)/46,XY at amniocentesis in a pregnancy associated with a favorable fetal outcome, perinatal progressive decrease of the aneuploid cell line and cytogenetic discrepancy between cultured amniocytes and uncultured amniocytes. Taiwanese Journal of Obstetrics and Gynecology. 63(5). 750–754.
6.
Chen, Kai‐Hsiang, et al.. (2024). Clinical manifestations and viral kinetics of people with Mpox: A case series during the 2023 outbreak in Taiwan. Journal of Microbiology Immunology and Infection. 57(6). 961–965.
7.
Chen, Guan‐Jhou, Hsin‐Yun Sun, Kuan‐Yin Lin, et al.. (2023). A Randomized Clinical Trial of 1-Dose vs Accelerated 2-Dose Schedule for Hepatitis A Virus (HAV) Revaccination Among People With Human Immunodeficiency Virus Who Were Nonresponders or Had Seroreversion After Primary HAV Vaccination. Clinical Infectious Diseases. 77(4). 529–536.
8.
Chao, Tai‐Ling, Ya‐Min Tsai, Pei‐Ching Chang, et al.. (2023). IFN‐stimulated metabolite transporter ENT3 facilitates viral genome release. EMBO Reports. 24(3). e55286–e55286.
9.
Chang, Sui‐Yuan, Yu‐Nong Gong, Chung‐Guei Huang, et al.. (2023). The emergence and successful elimination of SARS-CoV-2 dominant strains with increasing epidemic potential in Taiwan’s 2021 outbreak. Heliyon. 9(12). e22436–e22436.
10.
Chao, Tai‐Ling, Sui‐Yuan Chang, Chih‐Hao Lu, et al.. (2023). Dual Effects of 3-epi-betulin from Daphniphyllum glaucescens in Suppressing SARS-CoV-2-Induced Inflammation and Inhibiting Virus Entry. International Journal of Molecular Sciences. 24(23). 17040–17040.
11.
Liu, Wang-Da, Jann‐Tay Wang, Tai‐Ling Chao, et al.. (2022). Evolution of neutralizing antibodies and cross-activity against different variants of SARS-CoV-2 in patients recovering from COVID-19. Journal of the Formosan Medical Association. 122(8). 714–722.
12.
Chen, Guan‐Jhou, Hsin‐Yun Sun, Sui‐Yuan Chang, et al.. (2021). Incidence and impact of low-level viremia among people living with HIV who received protease inhibitor- or dolutegravir-based antiretroviral therapy. International Journal of Infectious Diseases. 105. 147–151.
13.
Cheng, Ya‐Wen, Tai‐Ling Chao, Hurng‐Yi Wang, et al.. (2021). D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage. mBio. 12(4). e0058721–e0058721.
14.
Kuo, Chih‐Jung, Tai‐Ling Chao, Ya‐Min Tsai, et al.. (2021). Kinetic Characterization and Inhibitor Screening for the Proteases Leading to Identification of Drugs against SARS-CoV-2. Antimicrobial Agents and Chemotherapy. 65(4).
15.
Sheng, Wang‐Huei, et al.. (2020). Dysosmia and dysgeusia in patients with COVID-19 in northern Taiwan. Journal of the Formosan Medical Association. 120(1). 311–317.
16.
Tsai, Mao‐Song, Sui‐Yuan Chang, Shu‐Wen Lin, et al.. (2016). Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study. Journal of Microbiology Immunology and Infection. 50(6). 789–797.
17.
Lin, Kuan‐Yin, Sih‐Han Liao, Wen‐Chun Liu, et al.. (2015). Cholelithiasis and Nephrolithiasis in HIV-Positive Patients in the Era of Combination Antiretroviral Therapy. PLoS ONE. 10(9). e0137660–e0137660.
18.
Lin, Hui‐Wen, Chia‐Jui Yang, Mao-Yuan Chen, et al.. (2015). Risk of recurrent nontyphoid Salmonella bacteremia in human immunodeficiency virus-infected patients with short-term secondary prophylaxis in the era of combination antiretroviral therapy. Journal of Microbiology Immunology and Infection. 49(5). 760–767.
19.
Sheng, Wang‐Huei, Chien‐Ching Hung, Sui‐Yuan Chang, et al.. (2011). Differential Clinical and Virologic Impact of Hepatitis B Virus Genotypes B and C on HIV-Coinfected Patients Receiving Lamivudine-Containing Highly Active Antiretroviral Therapy. Clinical Infectious Diseases. 54(4). 548–555.
20.
Chang, Sui‐Yuan, M.-Y. Chen, Chien‐Nan Lee, et al.. (2008). Trends of antiretroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in Taiwan. Journal of Antimicrobial Chemotherapy. 61(3). 689–693.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Hong Zhang Breakdown of academic impact, for papers by Miguel Ángel Martı́nez Breakdown of academic impact, for papers by Andrea Carfı́ Breakdown of academic impact, for papers by Hans Wilhelm Doerr Breakdown of academic impact, for papers by D. Lorne Tyrrell Breakdown of academic impact, for papers by Christopher D. Richardson Breakdown of academic impact, for papers by Andreas Meyerhans Breakdown of academic impact, for papers by Jie Zhou Breakdown of academic impact, for papers by Lu Lu Breakdown of academic impact, for papers by Zhenghong Yuan